Oral Mucositis

OSI recovers rights to market Gelclair in the oncology setting in N. America

Published in Medical Devices and Surgical Technology Week, July 13th, 2003

OSI Pharmaceuticals, Inc., (SIP) announced that it has entered into an agreement with Celgene Corp. by which OSI will recover full rights to market and promote Gelclair in the oncology setting in North America.

Gelclair is a bioadherent oral gel that provides relief for the treatment of pain associated with oral mucositis, a debilitating side effect often seen in cancer patients undergoing radiation treatment or chemotherapy. Previously, Gelclair was marketed to oncologists for their cancer patients under a copromotion agreement between Celgene and Cell Pathways, Inc. Gelclair was added to OSI's oncology portfolio as part of the company's recent acquisition of Cell...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week

Source: Medical Devices and Surgical Technology Week (2003-07-13)

More Articles from Medical Devices and Surgical Technology Week

Biomaterials
Biodegradable scaffold significantly increases rate of bone healing
Fetal Medicine
Skeletal radiographs used in assessing fetal death require skilled teams
Breast Cancer
Intraoperative imprint cytology of sentinel node could reduce operations
Face and Scalp Replantation
First replantation of face and scalp with single-artery repair is successful
Low Back Pain
Minimally invasive alternative offered to traditional spine fusion surgery
Orthopedics
Scientists identify two key risk factors for hip replacement in women
More from this issue of Medical Devices and Surgical Technology Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry